Medicare patients with highest COVID risks were less likely to get treatment

Medicare patients who were at the highest risk of severe COVID-19 infections were less likely to get Paxlovid or other treatments, according to new research.

Related Keywords

,Andrew Wilcock ,Gilead Sciences Inc ,Pfizer ,Centers For Disease ,Harvard Medical School ,Merck Co ,Veterans Health Administration ,Health Forum ,Pfizer Inc ,Drug Administration ,Us Department Of Veterans Affair ,Harvard Medical ,Gilead Sciences ,Morehouse School ,Satcher Health Leadership Institute ,Disease Control ,Veterans Affair ,Mortality Weekly ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Wholesalers ,Retail Wholesale ,Insurance ,Non Life Insurance ,Health Medical Insurance ,Healthcare Life Sciences ,Biopharmaceuticals ,Financial Services ,Government Sponsored Health Insurance ,Research Development ,Corporate Industrial News ,Biology ,Political General News ,Respiratory Tract Diseases ,Medical Research ,Health ,Medical Conditions ,Outbreaks Epidemics ,Novel Coronaviruses ,Sciences Humanities ,Infectious Diseases ,Medical Treatments Procedures ,Research ,Development ,Corporate ,Industrial News ,Political ,General News ,Outbreaks ,Epidemics ,Sciences ,Humanities ,Medical Treatments ,Procedures ,Retail ,Wholesale ,Medical Insurance ,Healthcare ,Life Sciences ,